AGN — Argenica Therapeutics Balance Sheet
0.000.00%
- AU$82.79m
- AU$74.36m
- AU$0.06m
Annual balance sheet for Argenica Therapeutics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Cash | ||||
Cash and Short Term Investments | 0.342 | 7.14 | 8.91 | 9.29 |
Net Total Receivables | 0.035 | 0.078 | 0.072 | 0.152 |
Prepaid Expenses | ||||
Total Other Current Assets | ||||
Total Current Assets | 0.377 | 7.27 | 9.04 | 9.54 |
Net Intangible Assets | ||||
Total Assets | 0.378 | 7.27 | 9.04 | 9.54 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 0.359 | 0.426 | 0.736 | 1.87 |
Total Long Term Debt | ||||
Total Debt | ||||
Total Liabilities | 0.359 | 0.426 | 0.736 | 1.87 |
Common Stock | ||||
Retained Earnings (Accumulated Deficit) | ||||
Total Equity | 0.018 | 6.85 | 8.31 | 7.67 |
Total Liabilities & Shareholders' Equity | 0.378 | 7.27 | 9.04 | 9.54 |
Total Common Shares Outstanding |